Inflammatory Biomarkers in Depression
The Carlat Psychiatry Report, Volume 18, Number 2, February 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Bupropion | C-Reactive Protein | CRP | Depression | Depressive Disorder | Dopamine | Exercise | Inflammation | Laboratory Testing in Psychiatry | Medical Comorbidities | Norepinephrine | Nortriptyline | Nutrition | Obesity | Treatment-Resistant Depression | Wellbutrin
Andrew H. Miller, MD
William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University, GA
Dr. Miller has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Andrew Miller, Vice Chair of Psychiatry Research at Emory University, translates two decades research on inflammation and depression into practical terms, including a low-cost biomarker that may guide antidepressant selection.
You can't view details of this content, please login or buy subscription here